These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10267698)

  • 1. Clinical pharmacy. Target drug programs can reduce some costs and avoid others.
    Cost Containment; 1984 Aug; 6(16):3-6. PubMed ID: 10267698
    [No Abstract]   [Full Text] [Related]  

  • 2. A lab-pharmacy push to cut drug therapy costs.
    Rydzewski MM
    MLO Med Lab Obs; 1984 Oct; 16(10):63-4, 69. PubMed ID: 10268396
    [No Abstract]   [Full Text] [Related]  

  • 3. Monitoring antibiotic prescriptions can reduce use and cost of drugs.
    Douglas AS
    Mod Healthc; 1984 Oct; 14(13):106-7. PubMed ID: 10268397
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical interventions reduce antimicrobial costs.
    Rao S; Machuga D
    Am J Hosp Pharm; 1994 Mar; 51(5):703. PubMed ID: 8203395
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving budget control: a case study.
    Karali J
    Hosp Cost Manag Account; 1993 May; 5(2):1-8. PubMed ID: 10125473
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
    Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA
    Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling moxalactam and cefotaxime use with a target drug program.
    Abramowitz PW; Ludwig DJ; Mansur JM; Nold EG
    Hosp Pharm; 1983 Aug; 18(8):416-20. PubMed ID: 10261791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost benefit of pharmacy audit and nonrestrictive antibiotic policy.
    Ware GJ; Ford DJ
    N Z Med J; 1993 Apr; 106(954):160. PubMed ID: 8479665
    [No Abstract]   [Full Text] [Related]  

  • 9. 'UR' pharmacists help MDs control drug costs.
    Anderson HJ
    Hospitals; 1993 Jan; 67(1):42. PubMed ID: 8418002
    [No Abstract]   [Full Text] [Related]  

  • 10. Contribution of clinical pharmacists to cefazolin utilization.
    Witte KW; Hatoum HT; Hoon TJ
    Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D; Thornton J
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. As hospital drug budgets soar, pharmacy's role is being rewritten.
    Lumsdon K
    Hospitals; 1992 May; 66(10):34, 36, 38-40. PubMed ID: 1577448
    [No Abstract]   [Full Text] [Related]  

  • 13. Slowing rate of cost increases in the pharmacy.
    Roark M
    Hospitals; 1993 Jan; 67(2):56. PubMed ID: 8419282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter survey of cefazolin usage.
    Steckel SD; Siskin SB
    Hosp Formul; 1981 Nov; 16(11):1284-6, 1291-3. PubMed ID: 10253176
    [No Abstract]   [Full Text] [Related]  

  • 15. Cephalosporin cost reduction.
    Martucci HJ; Parry MF
    Hosp Formul; 1981 Apr; 16(4):396-8, 403. PubMed ID: 10250718
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of factors influencing antibiotic usage in hospitals.
    Sabath LD; Notto DA
    Prog Clin Biol Res; 1979; 35():65-74. PubMed ID: 538037
    [No Abstract]   [Full Text] [Related]  

  • 17. Methods of controlling cephalosporin use in Canadian hospitals.
    Godin JP; Sketris IS; Merrett RA; Marrie TJ
    Can J Hosp Pharm; 1988 Apr; 41(2):73-4, 83-4, 96. PubMed ID: 10287052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of drug costs within diagnosis related groups.
    Kolar R; Stanaszek W; Osborne J; Dougherty K
    Hosp Pharm; 1984 Nov; 19(11):731-5. PubMed ID: 10310864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Economic prescription of drugs].
    Sonne J; Faber O
    Ugeskr Laeger; 2004 Apr; 166(18):1695. PubMed ID: 15174414
    [No Abstract]   [Full Text] [Related]  

  • 20. A targeted review of vancomycin use.
    Piquette RK
    Can J Hosp Pharm; 1991 Apr; 44(2):83-7. PubMed ID: 10111726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.